(Q33400442)

26 July 2017

title

Cisplatin preceded by concurrent cytarabine and hydroxyurea: a pilot study based on an in vitro model (English)

1 reference

26 July 2017

1 reference

1 reference

1 reference

K S Albain

1

1 reference

26 July 2017

L J Swinnen

2

1 reference

26 July 2017

L C Erickson

3

1 reference

26 July 2017

P J Stiff

4

1 reference

26 July 2017

R I Fisher

5

1 reference

26 July 2017

language of work or name

1 reference

1 January 1990

1 reference

Cancer Chemotherapy and Pharmacology

26 July 2017

published in

1 reference

26 July 2017

volume

27

1 reference

26 July 2017

issue

1

1 reference

26 July 2017

page(s)

33-40

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00689273

26 July 2017

exact match

0 references

cites work

Sequential hydroxyurea-cytarabine chemotherapy for refractory non-Hodgkin's lymphoma

1 reference

12 December 2020

Increased sensitivity of UV-repair-deficient human cells to DNA bound platinum products which unlike thymine dimers are not recognized by an endonuclease extracted from Micrococcus luteus

1 reference

12 December 2020

Ultraviolet irradiation produces cytotoxic synergy and increased DNA interstrand crosslinking with cis- and trans-diamminedichloroplatinum(II).

1 reference

12 December 2020

Studies of hydroxyurea administered by continuous infusion: toxicity, pharmacokinetics, and cell synchronization

1 reference

12 December 2020

Phase I trial of cytarabine and hydroxyurea.

1 reference

12 December 2020

Pharmacokinetics of non-protein-bound platinum species following administration of cis-dichlorodiammineplatinum(II)

1 reference

12 December 2020

Plasma levels and urinary excretion of filterable platinum species following bolus injection and iv infusion of cis-dichlorodiammineplatinum(II) in man

1 reference

12 December 2020

RENAL ABNORMALITIES INDUCED BY HYDROXYUREA (NSC-32065)

1 reference

12 December 2020

Saturation of ara-CTP accumulation during high-dose ara-C therapy: pharmacologic rationale for intermediate-dose ara-C

1 reference

12 December 2020

The role of deoxynucleoside triphosphate pools in the inhibition of DNA-excision repair and replication in human cells by hydroxyurea

1 reference

12 December 2020

The Mechanism of Action of Antitumor Platinum Compounds

1 reference

12 December 2020

Studies on the absorption, distribution, and excretion of hydroxyurea (NSC-32065)

1 reference

12 December 2020

Hydroxyurea (NSC-32065) in biologic fluids: dose-concentration relationship

1 reference

12 December 2020

Pharmacokinetics of free and total platinum species after rapid and prolonged infusions of cisplatin

1 reference

12 December 2020

A method of analyzing for hydroxyurea in biological fluids

1 reference

12 December 2020

Increased activation of 1-beta-D-arabinofuranosylcytosine by hydroxyurea in L1210 cells

1 reference

12 December 2020

Defective removal of DNA cross-links in a repair-deficient mutant of Chinese hamster cells.

1 reference

12 December 2020

Synergistic interaction between 1-beta-D-arabinofuranosylcytosine, thymidine, and hydroxyurea against human B cells and leukemic blasts in vitro

1 reference

12 December 2020

Formation and repair of DNA interstrand cross-links in relation to cytotoxicity and unscheduled DNA synthesis induced in control and mutant human cells treated with cis-diamminedichloroplatinum(II)

1 reference

12 December 2020

1-beta-D-arabinofuranosylcytosine and hydroxyurea production of cytotoxic synergy with cis-diamminedichloroplatinum(II) and modification of platinum-induced DNA interstrand cross-linking

1 reference

12 December 2020

Continuous infusion of high-dose 1-beta-D-arabinofuranosylcytosine: a phase I and pharmacological study

1 reference

12 December 2020

Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP).

1 reference

12 December 2020

Apurinic/apyrimidinic endonucleases in repair of pyrimidine dimers and other lesions in DNA.

1 reference

12 December 2020

Clinical and biochemical studies of high-dose intermittent therapy of solid tumors with hydroxyurea (NSC-32065)

1 reference

12 December 2020

Effect of 1-beta-D-arabinofuranosyl cytosine and hydroxyurea on the repair of X-ray-induced DNA single-strand breaks in human leukemic blasts.

1 reference

12 December 2020

Creatinine clearance as a predictor of ultrafilterable platinum disposition in cancer patients treated with cisplatin: relationship between peak ultrafilterable platinum plasma levels and nephrotoxicity

1 reference

12 December 2020

The effect of cytosine arabinoside on the frequency of single-strand breaks in DNA of mammalian cells following irradiation or chemical treatment

1 reference

12 December 2020

Inhibition of DNA excision repair in human cells by arabinofuranosyl cytosine: effect on normal and xeroderma pigmentosum cells

1 reference

12 December 2020

Studies on mutagenesis and repair induced by platinum analogs

1 reference

12 December 2020

Potentiation of ara-C induced cytotoxicity by hydroxyurea in LoVo colon carcinoma cells.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00689273

1 reference

Dimensions Publication ID

26 July 2017

1022942794

0 references

Fatcat ID

release_d4o6fr6a4vd6bfjltorg5gfure

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/d4o6fr6a4vd6bfjltorg5gfure

24 November 2022

mapped directly with Wikidata item

1 reference